Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
- 2018 -
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
Oktober 2018 - 22 products
IP
CI
Lacri-Vision
20 x 0.65 ml
5.50
15.20
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Lacri-Vision
60 x 0.65 ml
15.68
33.45
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Lacri-Vision
90 x 0.65 ml
23.51
42.00
10 %
Ophtalmic gel: Natrii Hyaluronas
OmniVision AG
B / SL / SG
FB
G
IP
CI
Bimatoprost-Mepha Plus
3 ml
15.14
32.90
10 %
Eye drops: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bimatoprost-Mepha Plus
3 x 3 ml
43.19
63.40
10 %
Eye drops: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Movymia
239.81
278.40
10 %
Injection solution: Teriparatidum Adnr 250 µg/ml
Spirig HealthCare AG
B / SL
FB
G
L
IP
VEYVONDI 650 IE
650
532.84
587.75
10 %
Lyophilisate and solvent: Vonicogum Alfa 650 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
VEYVONDI 1300 IE
1300
1065.68
1134.45
10 %
Lyophilisate and solvent: Vonicogum Alfa 1300 UI
Takeda Pharma AG
B / SL
FB
G
IP
CI
Plenvu
3
11.88
29.35
10 %
Soluble Powder: 4 Active Agents
Soluble Powder: 3 Active Agents
Soluble Powder: 2 Active Agents
Norgine AG
B / SL
FB
G
L
IP
CI
Steglatro 5 mg
28
38.39
58.15
10 %
Coated tablets: Ertugliflozinum 5 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
CI
Steglatro 5 mg
98
134.36
162.55
10 %
Coated tablets: Ertugliflozinum 5 mg
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
CI
Steglujan 5 mg /100 mg
28
58.33
79.85
10 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
CI
Steglujan 5 mg /100 mg
98
204.16
238.45
10 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
IP
CI
Kymriah
PR
PR
k.A.
Novartis Pharma
Schweiz AG
A
FB
G
IP
SmofKabiven special 1012 ml
4 x 1012 ml
PR
PR
k.A.
Infusion emulsion: 22 Active Agents
Infusion emulsion: Glucosum
Infusion emulsion: 4 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven special 1518 ml
4 x 1518 ml
PR
PR
k.A.
Infusion emulsion: 22 Active Agents
Infusion emulsion: Glucosum
Infusion emulsion: 4 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
CI
Movymia
3
PR
PR
k.A.
Injection solution: Teriparatidum Adnr 250 µg/ml
Spirig HealthCare AG
B
FB
G
IP
CI
Aripiprazol-Mepha 1mg/ml
150 ml
PR
PR
k.A.
Sirup: Aripiprazolum 1 mg/ml
Mepha Pharma AG
B
FB
G
IP
CI
Zejula 100 mg
28
PR
PR
k.A.
Capsules: Niraparibum 100 mg
GlaxoSmithKline AG
A
FB
G
IP
CI
Zejula 100 mg
56
4625.24
5046.65
k.A.
Capsules: Niraparibum 100 mg
GlaxoSmithKline AG
A
FB
G
IP
CI
Zejula 100 mg
84
6937.86
7426.05
k.A.
Capsules: Niraparibum 100 mg
GlaxoSmithKline AG
A
FB
G
IP
Netspot 40 mcg
PR
PR
k.A.
kit for radiopharmaceutical preparation: Oxodotreotidum 40 µg
Kit für ein radioaktives Arzneimittel: Oxodotreotidum 40 µg
Novartis Pharma
Schweiz AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home